FDAsafety guidance66% confidence
Pharmacy Compounding Advisory Committee Roster
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as Novitium Pharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
This page contains the PCAC roster, which lists the current members and the current number of vacancies for the committee.
Supporting Context
- Therapeutic area
- Pain Management · NSAID
- Sub-indication
- Pain
Related signal: FDA Accepts Supplement for Naproxen by Novitium Pharma